Race-based therapeutics.

@article{Bloche2004RacebasedT,
  title={Race-based therapeutics.},
  author={M. Bloche},
  journal={The New England journal of medicine},
  year={2004},
  volume={351 20},
  pages={
          2035-7
        }
}
  • M. Bloche
  • Published 2004
  • Medicine
  • The New England journal of medicine
Are we moving into a new era of race-based therapeutics? Dr. M. Gregg Bloche asserts that greater awareness that race is at best a placeholder for other predispositions, and not a biologic verity, would be a first step. 
139 Citations
BiDil: Assessing a Race-Based Pharmaceutical
  • 53
  • PDF
Race, Money and Medicines
  • M. Bloche
  • Psychology, Medicine
  • The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
  • 2006
  • 12
  • PDF
Race‐based therapeutics A discussion surrounding heart failure trials
  • Natalie Schmitz
  • Medicine
  • JAAPA : official journal of the American Academy of Physician Assistants
  • 2007
Racial medicine: here to stay?
  • 11
BiDil in the Clinic: An Interdisciplinary Investigation of Physicians’ Prescription Patterns of a Race-Based Therapy
  • 8
  • Highly Influenced
...
1
2
3
4
5
...

References

SHOWING 1-8 OF 8 REFERENCES
How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.
  • J. Kahn
  • Medicine
  • Yale journal of health policy, law, and ethics
  • 2004
  • 170
  • PDF
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
  • 1,136
  • PDF
Social Isolation and Health, with an Emphasis on Underlying Mechanisms
  • 535
A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure
  • N Engl J Med
  • 1991
A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure
  • N Engl J Med
  • 1991